November 9, 2008Open Access
View Full PaperRosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Key Points
Key points are not available for this paper at this time.
Abstract
In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence of major cardiovascular events. (ClinicalTrials.gov number, NCT00239681.)